- $50.27m
- $67.37m
- $22.36m
Brief: DarioHealth Announces Preliminary Fourth Quarter 2022 Operating Results
Brief: DarioHealth Files Prospectus For Offering Of Up To 107,409 Shares
DarioHealth jumps as B2B segment drives Q3 revenue beat
DarioHealth Corp reports results for the quarter ended in September - Earnings Summary
Brief: DarioHealth Reports Third Quarter 2022 Financial, Operating Results
DarioHealth Corp expected to post a loss of 76 cents a share - Earnings Preview
Brief: Dario Announces Two Employer Contracts For Full Suite Of Digital Health Solutions
Brief: DarioHealth Announces New Employer Contracts
U.S. RESEARCH ROUNDUP- Aptinyx, Rapid Micro Biosystems, Trinet Group
DarioHealth falls on weak Q2 revenue
DarioHealth Corp reports results for the quarter ended in June - Earnings Summary
Brief: Dariohealth Corp Reports Q2 Revenue Of $6.2 Million, A 17.5% Increase
DarioHealth Corp expected to post a loss of 71 cents a share - Earnings Preview
Brief: DarioHealth Announces New Contract To Deliver Its Full Suite Of Integrated Chronic Condition Management Solutions
Brief: Dariohealth Announces New Contract With A National Employer
Brief: Dariohealth Secures $50 Million Dollar Non-Dilutive Credit Facility With Orbimed
Brief: DarioHealth Corp - On May 30, Co Was Informed Of Death Of Richard Stone, Member Of Co's Board
Brief: Dariohealth Presents Three New Studies Demonstrating Improved Health In Users With Multiple Conditions At The American Diabetes Association's 82nd Scientific Sessions
Brief: DarioHealth Announces Additional Commercial Contracts for its Digital Therapeutic Solutions